Taking people in Hollandia1/2. fázis
Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study
Key facts
- Where
- Leiden és Rotterdam, HollandiaSee the 2 sites
- Phase
- 1/2. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Hollandia
- Academisch Ziekenhuis LeidenLeiden, HollandiaTaking people
- Diabeter Nederland B.V.Rotterdam, HollandiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Academisch Ziekenhuis Leiden
- Trial code
- EU 2023-508558-25-01
- Record updated
- 2026. március 24.